Method of forming inorganic nanocages

US10688556B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10688556-B2
Application numberUS-201715477601-A
CountryUS
Kind codeB2
Filing dateApr 3, 2017
Priority dateApr 1, 2016
Publication dateJun 23, 2020
Grant dateJun 23, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nanocages are formed by etching nancubes. The nanocubes are added to an aqueous system having an amphiphilic lipid dissolved in an organic solvent (e.g. a hydrophobic alcohol) to form reverse micelles. As the water evaporates the micelles shrink as etching of the flat surface of the nanocubes occurs. In this fashion hollow nanocages are produced. In one embodiment, the nanocage is covalently attached to a polymer shell (e.g. a dextran shell).

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of forming a nanocage, the method comprising sequential steps of: forming a reverse micelle system comprising an inorganic nanocube consisting of palladium, the inorganic nanocube having a diameter of 15 nm or less, the reverse micelle system further comprising an amphiphilic lipid, water and an organic solvent that is immiscible with water and has a boiling point greater than 100° C., removing the water by evaporation, the step of removing causing the inorganic nanocube to undergo atomic desorption in an etchant-free environment to form a nanocage, wherein the nanocage has a diameter less than the diameter of the inorganic nanocube; isolating the nanocage; attaching a dextran polymer to the nanocage thereby forming a nanocage-polymer complex that has a diameter of less than 50 nm. 2. The method as recited in claim 1 , wherein the nanocage is covalently attached to the dextran polymer shell by a dopamine linking group. 3. The method as recited in claim 1 , wherein the dextran polymer comprises an aminodextran. 4. The method as recited in claim 1 , wherein the amphiphilic lipid is selected from a group consisting of cetyl-trimethylammonium bromide, hexadecyl trimethyl ammonium chloride, sodium dodecyl sulfate, sodium dodecyl benzene sulfonate, oleic acid and oleylamine. 5. The method as recited in claim 1 , wherein the organic solvent is octanol. 6. The method as recited in claim 1 , wherein the amphiphilic lipid is cetyl-trimethylammonium bromide; the organic solvent is octanol. 7. A method of forming a nanocage, the method comprising sequential steps of: forming a reverse micelle system comprising an inorganic nanocube consisting of iron oxide having a diameter of 15 nm or less, the reverse micelle system further comprising an amphiphilic lipid, water and an organic solvent that is immiscible with water and has a boiling point greater than 100° C.; removing the water by evaporation, the step of removing causing the inorganic nanocube to undergo atomic desorption in an etchant-free environment to form an iron oxide nanocage, wherein the iron oxide nanocage has a diameter less than the diameter of the inorganic nanocube; isolating the nanocage; attaching a dextran polymer to the iron oxide nanocage to form a nanocage-polymer complex with a diameter of less than 50 nm and the iron oxide nanocage is attached to the dextran polymer shell by a catechol linking group. 8. The method as recited in claim 7 , wherein the catechol is a dopamine. 9. The method as recited in claim 7 , wherein the dextran comprises an aminodextran.

Assignees

Inventors

Classifications

  • Metallic powder coated with organic material · CPC title

  • Chemical treatment, e.g. passivation or decarburisation · CPC title

  • Complex form nanoparticles, e.g. prism, pyramid, octahedron · CPC title

  • B22F1/054Primary

    Nanosized particles · CPC title

  • Oxides of iron · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10688556B2 cover?
Nanocages are formed by etching nancubes. The nanocubes are added to an aqueous system having an amphiphilic lipid dissolved in an organic solvent (e.g. a hydrophobic alcohol) to form reverse micelles. As the water evaporates the micelles shrink as etching of the flat surface of the nanocubes occurs. In this fashion hollow nanocages are produced. In one embodiment, the nanocage is covalently at…
Who is the assignee on this patent?
Univ City New York Res Found
What technology area does this patent fall under?
Primary CPC classification B22F1/054. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).